Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Kechuanning Tablets
- Development stage
- Unknown
- Lead developer
- Dalian Tianshan Pharmaceutical
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Kechuanning Tablets (咳喘宁片) is a Traditional Chinese Medicine (TCM) formulation developed by Wuhan United Pharmacy for the treatment of respiratory ailments. Administered orally in tablet form, the drug is specifically indicated for cough and asthma. It is a plant-derived formulation that has been approved for marketing in China. Like many TCM products, its therapeutic effect is derived from a complex mixture of botanical extracts, and it does not have a single defined molecular target in the traditional biotech sense.
- Brand names
- Kechuanning Tablets咳喘宁片
- Other names
- KechuanningKechuanning Pian
Beyond the preview
Go deeper on Kechuanning Tablets.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Kechuanning Tablets.